pancreatic cancer

Hereditary mutations in cancer: the use of panels and genetic counselling

Number 82

Featured, Grandround 25 May 2018 0

Testing for hereditary mutations that increase the risk of cancer is important for risk reduction, early detection and choice of treatment. Ephrat Levy-Lahad offers an overview of what we know ‒ and what remains uncertain [more]

Don’t shoot the driver! It’s about taxonomy more than targets

Number 81

Cutting Edge, Featured 9 March 2018 2

Could tailoring treatments to broad taxonomies work where targeting individual – or even multiple – genetic mutations has not? A growing number of researchers working on specific tumour types and/or across tumours believe this integrative [more]

Newsround

Number 69

Senza categoria 1 December 2015 0

Higher quality colonoscopies reduce cancer deaths without higher costs => JAMA Higher rates of detection of precancerous adenoma were associated with lower lifetime risks of colorectal cancer and colorectal cancer mortality and did not result [more]

Newsround

Number 64

Senza categoria 1 January 2015 0

Statins improve survival in colorectal cancer => Journal of Clinical Oncology Using statins after a diagnosis of colorectal cancer was found to be associated with improved survival, finds a large population-based cohort study. The study, [more]

Newsround

Number 58

Senza categoria 1 January 2014 0

Selected reports edited by Janet Fricker Clinical trials lead to cost savings => British Journal of Cancer On average, non-commercial oncology clinical trials are associated with small excess treatment costs compared to the standard of [more]

Newsround

Number 49

Senza categoria 1 July 2012 0

Selected reports edited by Janet Fricker Stereotactic body radiation therapy for spinal metastases => Lancet Oncology Stereotactic body radiation therapy (SBRT) delivers significant reductions in patient-reported pain and other symptoms six months post treatment, a [more]

Management of metastatic pancreatic cancer: current strategies and future directions

Number 40

Grandround 1 January 2011 0

Despite recent progress, pancreatic cancer remains one of the worst cancer diagnoses. Malcolm Moore reviews current management and considers future progress. Download full article

Adjuvant EBRT improves survival in patients with lymph-node-negative pancreatic cancer

Number 26

Impact Factor 1 September 2008 0

Though the role of radiation therapy in the adjuvant treatment of pancreatic cancer remains controversial, a recent large retrospective study indicates that radiation is associated with improved survival. Download full article

Comparison of gemcitabine plus platinum analogue with gemcitabine alone in advanced pancreatic cancer

Number 25

Impact Factor 1 July 2008 0

A pooled analysis of two randomised trials has shown that gemcitabine in combination with a platinumanalogue (cisplatin or oxaliplatin) is a potential front-line treatment option in advanced pancreatic adenocarcinoma. Download full article

Ne w s r o u n d

Number 19

Senza categoria 1 August 2007 0

Download full article

N E W S R O U N D

Number 17

Senza categoria 1 March 2007 0

Selected press reports compiled by the ESO Download full article

NEWSROUND

Number 9

Senza categoria 1 November 2005 0

Selected Press Reports compiled by the Cancer Media Centre Download full article